AGP Picks
View all

Grenada Economic Digest
Provided by AGP

Grenada Economic Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Grenada Economic Digest.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on September 29, 2026

NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs
Sep. 29, 2026

NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs

Indeterminate GlobeNewswire
NFI schedules third quarter 2026 financial results and conference call
Sep. 29, 2026

NFI schedules third quarter 2026 financial results and conference call

Indeterminate GlobeNewswire
DeFi Technologies’ Subsidiary Valour Launches Zcash (ZEC) ETP
Sep. 29, 2026

DeFi Technologies’ Subsidiary Valour Launches Zcash (ZEC) ETP

Indeterminate GlobeNewswire
Jeffrey Hecht Joins FTI Consulting to Lead Private Equity Tax and Advisory Services
Sep. 29, 2026

Jeffrey Hecht Joins FTI Consulting to Lead Private Equity Tax and Advisory Services

Indeterminate GlobeNewswire
Knight Therapeutics Enters into Exclusive Distribution Agreement with Kyowa Kirin International for Poteligeo® (Mogamulizumab)
Sep. 29, 2026

Knight Therapeutics Enters into Exclusive Distribution Agreement with Kyowa Kirin International for Poteligeo® (Mogamulizumab)

Indeterminate GlobeNewswire
Thérapeutique Knight conclut une entente de distribution exclusive avec Kyowa Kirin International pour Poteligeo® (Mogamulizumab)
Sep. 29, 2026

Thérapeutique Knight conclut une entente de distribution exclusive avec Kyowa Kirin International pour Poteligeo® (Mogamulizumab)

Indeterminate GlobeNewswire
Midland Appoints Jean-François Larivière as Vice President Exploration
Sep. 29, 2026

Midland Appoints Jean-François Larivière as Vice President Exploration

Indeterminate GlobeNewswire
Midland nomme Jean-François Larivière au poste de Vice-Président Exploration
Sep. 29, 2026

Midland nomme Jean-François Larivière au poste de Vice-Président Exploration

Indeterminate GlobeNewswire
Kobo Resources Intersects Strong Gold Mineralisation at the Road Cut Zone with 19.0 m at 1.94 g/t Au; Northern Drilling Identifies Potential Areas for Future Resource Growth
Sep. 29, 2026

Kobo Resources Intersects Strong Gold Mineralisation at the Road Cut Zone with 19.0 m at 1.94 g/t Au; Northern Drilling Identifies Potential Areas for Future Resource Growth

Indeterminate GlobeNewswire
Ressources Kobo recoupe une importante minéralisation aurifère dans la zone Road Cut, soit 19,0 m à 1,94 g/t Au; Le forage au nord établit des zones potentielles pour la croissance future des ressources
Sep. 29, 2026

Ressources Kobo recoupe une importante minéralisation aurifère dans la zone Road Cut, soit 19,0 m à 1,94 g/t Au; Le forage au nord établit des zones potentielles pour la croissance future des ressources

Indeterminate GlobeNewswire
StorageVault Announces Repayment at Maturity of its 5.50% Senior Unsecured Hybrid Debentures Due September 30, 2026
Sep. 29, 2026

StorageVault Announces Repayment at Maturity of its 5.50% Senior Unsecured Hybrid Debentures Due September 30, 2026

Indeterminate GlobeNewswire
Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Workshop for Waldenström Macroglobulinemia
Sep. 29, 2026

Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Workshop for Waldenström Macroglobulinemia

Indeterminate GlobeNewswire
HPQ and PyroGenesis Close 50/50 Ownership of HPQ Silica Polvere
Sep. 29, 2026

HPQ and PyroGenesis Close 50/50 Ownership of HPQ Silica Polvere

Indeterminate GlobeNewswire
HPQ et PyroGenèse finalisent la structure de propriété à parts égales (50/50) de HPQ Silica Polvere
Sep. 29, 2026

HPQ et PyroGenèse finalisent la structure de propriété à parts égales (50/50) de HPQ Silica Polvere

Indeterminate GlobeNewswire
NYSE: MMA – MMA.INC Raises Annualized Cash Operating Cost Reductions to over US$2.51 Million, Accelerating the Path Toward Positive Adjusted EBITDA
Sep. 29, 2026

NYSE: MMA – MMA.INC Raises Annualized Cash Operating Cost Reductions to over US$2.51 Million, Accelerating the Path Toward Positive Adjusted EBITDA

Indeterminate GlobeNewswire
HdL Companies Recognized for Employee Ownership Excellence Amid Continued Growth
Sep. 29, 2026

HdL Companies Recognized for Employee Ownership Excellence Amid Continued Growth

Indeterminate GlobeNewswire
Esker Infrastructure Corp. (formerly Cielo Waste Solutions Corp.) Completes Name Change to Reflect its Strategy as a Low-Carbon Energy Infrastructure Platform
Sep. 29, 2026

Esker Infrastructure Corp. (formerly Cielo Waste Solutions Corp.) Completes Name Change to Reflect its Strategy as a Low-Carbon Energy Infrastructure Platform

Indeterminate GlobeNewswire
TruGolf and Polymath to Present at The ThinkEquity Conference in New York on October 15
Sep. 29, 2026

TruGolf and Polymath to Present at The ThinkEquity Conference in New York on October 15

Indeterminate GlobeNewswire
Polar Power Receives Trial Order for 50 Propane-Fueled DC Generators from Major Southeast Asian Telecom Operator
Sep. 29, 2026

Polar Power Receives Trial Order for 50 Propane-Fueled DC Generators from Major Southeast Asian Telecom Operator

Indeterminate GlobeNewswire
uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington’s Disease Showing Continued Slowing of Disease Progression
Sep. 29, 2026

uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington’s Disease Showing Continued Slowing of Disease Progression

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Grenada Economic Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.